nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Serotonin Uptake Inhibitors—Sibutramine—obesity	0.387	1	CiPCiCtD
Escitalopram—bipolar disorder—Topiramate—obesity	0.168	1	CpDpCtD
Escitalopram—HTR2C—obesity	0.0571	0.547	CbGaD
Escitalopram—SLC6A4—obesity	0.0473	0.453	CbGaD
Escitalopram—SLC6A3—Diethylpropion—obesity	0.0188	0.0789	CbGbCtD
Escitalopram—SLC6A3—Sibutramine—obesity	0.0143	0.0598	CbGbCtD
Escitalopram—SLC6A3—Phendimetrazine—obesity	0.0143	0.0598	CbGbCtD
Escitalopram—SLC6A2—Diethylpropion—obesity	0.0138	0.0578	CbGbCtD
Escitalopram—SLC6A4—Sibutramine—obesity	0.0125	0.0523	CbGbCtD
Escitalopram—SLC6A3—Benzphetamine—obesity	0.0108	0.0453	CbGbCtD
Escitalopram—SLC6A3—Phentermine—obesity	0.0108	0.0453	CbGbCtD
Escitalopram—SLC6A2—Phendimetrazine—obesity	0.0104	0.0438	CbGbCtD
Escitalopram—SLC6A2—Sibutramine—obesity	0.0104	0.0438	CbGbCtD
Escitalopram—SLC6A3—Phenylpropanolamine—obesity	0.0103	0.0432	CbGbCtD
Escitalopram—SLC6A4—Phentermine—obesity	0.00947	0.0397	CbGbCtD
Escitalopram—SLC6A3—Bupropion—obesity	0.0092	0.0385	CbGbCtD
Escitalopram—ADRA1A—Phendimetrazine—obesity	0.00903	0.0378	CbGbCtD
Escitalopram—SLC6A3—Methamphetamine—obesity	0.00865	0.0362	CbGbCtD
Escitalopram—SLC6A2—Benzphetamine—obesity	0.00792	0.0332	CbGbCtD
Escitalopram—SLC6A2—Phentermine—obesity	0.00792	0.0332	CbGbCtD
Escitalopram—SLC6A4—Methamphetamine—obesity	0.00757	0.0317	CbGbCtD
Escitalopram—SLC6A2—Phenylpropanolamine—obesity	0.00756	0.0317	CbGbCtD
Escitalopram—ADRA1A—Benzphetamine—obesity	0.00684	0.0287	CbGbCtD
Escitalopram—SLC6A2—Bupropion—obesity	0.00673	0.0282	CbGbCtD
Escitalopram—ADRA1A—Phenylpropanolamine—obesity	0.00653	0.0274	CbGbCtD
Escitalopram—SLC6A2—Methamphetamine—obesity	0.00633	0.0265	CbGbCtD
Escitalopram—CYP2D6—Phentermine—obesity	0.00237	0.00995	CbGbCtD
Escitalopram—CYP2D6—Bupropion—obesity	0.00202	0.00846	CbGbCtD
Escitalopram—CYP3A4—Sibutramine—obesity	0.00199	0.00835	CbGbCtD
Escitalopram—CYP2C19—Cimetidine—obesity	0.00195	0.00817	CbGbCtD
Escitalopram—CYP2D6—Methamphetamine—obesity	0.0019	0.00795	CbGbCtD
Escitalopram—CYP3A4—Benzphetamine—obesity	0.00151	0.00633	CbGbCtD
Escitalopram—CYP2D6—Cimetidine—obesity	0.00148	0.00621	CbGbCtD
Escitalopram—CYP3A4—Bupropion—obesity	0.00128	0.00538	CbGbCtD
Escitalopram—CYP2C19—Topiramate—obesity	0.00128	0.00535	CbGbCtD
Escitalopram—CYP3A4—Orlistat—obesity	0.00105	0.00438	CbGbCtD
Escitalopram—CYP3A4—Cimetidine—obesity	0.000942	0.00395	CbGbCtD
Escitalopram—SLC6A2—sympathetic nervous system—obesity	0.00093	0.181	CbGeAlD
Escitalopram—SLC6A2—autonomic nervous system—obesity	0.000625	0.122	CbGeAlD
Escitalopram—CYP3A4—Topiramate—obesity	0.000617	0.00258	CbGbCtD
Escitalopram—Citalopram—HTR2C—obesity	0.000391	0.381	CrCbGaD
Escitalopram—SLC6A3—hindbrain—obesity	0.000327	0.0636	CbGeAlD
Escitalopram—Citalopram—SLC6A4—obesity	0.000324	0.316	CrCbGaD
Escitalopram—Citalopram—CYP2E1—obesity	0.00031	0.303	CrCbGaD
Escitalopram—SLC6A4—hindbrain—obesity	0.000299	0.0583	CbGeAlD
Escitalopram—ADRA1A—hindbrain—obesity	0.000245	0.0477	CbGeAlD
Escitalopram—SLC6A3—respiratory system—obesity	0.000199	0.0388	CbGeAlD
Escitalopram—SLC6A4—respiratory system—obesity	0.000183	0.0356	CbGeAlD
Escitalopram—SLC6A2—respiratory system—obesity	0.000161	0.0313	CbGeAlD
Escitalopram—CYP2D6—hindbrain—obesity	0.000144	0.0281	CbGeAlD
Escitalopram—CHRM1—cardiovascular system—obesity	0.000139	0.0272	CbGeAlD
Escitalopram—SLC6A4—digestive system—obesity	0.000116	0.0226	CbGeAlD
Escitalopram—HRH1—respiratory system—obesity	0.000116	0.0226	CbGeAlD
Escitalopram—ADRA1A—cardiovascular system—obesity	0.000115	0.0223	CbGeAlD
Escitalopram—ADRA1A—adipose tissue—obesity	0.000101	0.0197	CbGeAlD
Escitalopram—SLC6A2—adrenal gland—obesity	9.75e-05	0.019	CbGeAlD
Escitalopram—CYP2C19—digestive system—obesity	9.63e-05	0.0188	CbGeAlD
Escitalopram—SLC6A4—endocrine gland—obesity	9.6e-05	0.0187	CbGeAlD
Escitalopram—CHRM1—endocrine gland—obesity	9.56e-05	0.0186	CbGeAlD
Escitalopram—ADRA1A—adrenal gland—obesity	9.06e-05	0.0176	CbGeAlD
Escitalopram—SLC6A2—endocrine gland—obesity	8.45e-05	0.0165	CbGeAlD
Escitalopram—CYP2C19—endocrine gland—obesity	7.96e-05	0.0155	CbGeAlD
Escitalopram—ADRA1A—endocrine gland—obesity	7.86e-05	0.0153	CbGeAlD
Escitalopram—HRH1—adipose tissue—obesity	7.82e-05	0.0152	CbGeAlD
Escitalopram—HRH1—digestive system—obesity	7.36e-05	0.0143	CbGeAlD
Escitalopram—CYP2C19—liver—obesity	7.17e-05	0.014	CbGeAlD
Escitalopram—ADRA1A—liver—obesity	7.09e-05	0.0138	CbGeAlD
Escitalopram—HRH1—adrenal gland—obesity	7.02e-05	0.0137	CbGeAlD
Escitalopram—HRH1—endocrine gland—obesity	6.08e-05	0.0118	CbGeAlD
Escitalopram—CYP3A4—digestive system—obesity	5.69e-05	0.0111	CbGeAlD
Escitalopram—CYP2D6—digestive system—obesity	5.6e-05	0.0109	CbGeAlD
Escitalopram—CYP3A4—endocrine gland—obesity	4.7e-05	0.00916	CbGeAlD
Escitalopram—CYP2D6—endocrine gland—obesity	4.63e-05	0.00901	CbGeAlD
Escitalopram—CYP3A4—liver—obesity	4.24e-05	0.00826	CbGeAlD
Escitalopram—CYP2D6—liver—obesity	4.17e-05	0.00813	CbGeAlD
Escitalopram—Dry mouth—Sibutramine—obesity	1.47e-05	0.000219	CcSEcCtD
Escitalopram—Toxic epidermal necrolysis—Topiramate—obesity	1.47e-05	0.000218	CcSEcCtD
Escitalopram—Aspartate aminotransferase increased—Topiramate—obesity	1.47e-05	0.000218	CcSEcCtD
Escitalopram—Nervous system disorder—Orlistat—obesity	1.46e-05	0.000217	CcSEcCtD
Escitalopram—Nasopharyngitis—Topiramate—obesity	1.46e-05	0.000217	CcSEcCtD
Escitalopram—Confusional state—Sibutramine—obesity	1.45e-05	0.000216	CcSEcCtD
Escitalopram—Vision blurred—Bupropion—obesity	1.45e-05	0.000216	CcSEcCtD
Escitalopram—Skin disorder—Orlistat—obesity	1.45e-05	0.000215	CcSEcCtD
Escitalopram—Tremor—Bupropion—obesity	1.44e-05	0.000215	CcSEcCtD
Escitalopram—Gastritis—Topiramate—obesity	1.44e-05	0.000215	CcSEcCtD
Escitalopram—Anaphylactic shock—Sibutramine—obesity	1.44e-05	0.000215	CcSEcCtD
Escitalopram—Oedema—Sibutramine—obesity	1.44e-05	0.000215	CcSEcCtD
Escitalopram—Hyperhidrosis—Orlistat—obesity	1.44e-05	0.000214	CcSEcCtD
Escitalopram—Muscular weakness—Topiramate—obesity	1.44e-05	0.000214	CcSEcCtD
Escitalopram—Alanine aminotransferase increased—Topiramate—obesity	1.44e-05	0.000214	CcSEcCtD
Escitalopram—Infection—Sibutramine—obesity	1.43e-05	0.000213	CcSEcCtD
Escitalopram—Ill-defined disorder—Bupropion—obesity	1.43e-05	0.000213	CcSEcCtD
Escitalopram—Anaemia—Bupropion—obesity	1.42e-05	0.000212	CcSEcCtD
Escitalopram—Shock—Sibutramine—obesity	1.42e-05	0.000211	CcSEcCtD
Escitalopram—Abdominal distension—Topiramate—obesity	1.42e-05	0.000211	CcSEcCtD
Escitalopram—Agitation—Bupropion—obesity	1.42e-05	0.000211	CcSEcCtD
Escitalopram—Thrombocytopenia—Sibutramine—obesity	1.41e-05	0.00021	CcSEcCtD
Escitalopram—Dysphagia—Topiramate—obesity	1.41e-05	0.00021	CcSEcCtD
Escitalopram—Asthma—Topiramate—obesity	1.41e-05	0.00021	CcSEcCtD
Escitalopram—Angioedema—Bupropion—obesity	1.41e-05	0.000209	CcSEcCtD
Escitalopram—Tachycardia—Sibutramine—obesity	1.41e-05	0.000209	CcSEcCtD
Escitalopram—Skin disorder—Sibutramine—obesity	1.4e-05	0.000208	CcSEcCtD
Escitalopram—Eosinophilia—Topiramate—obesity	1.39e-05	0.000207	CcSEcCtD
Escitalopram—Hyperhidrosis—Sibutramine—obesity	1.39e-05	0.000207	CcSEcCtD
Escitalopram—Malaise—Bupropion—obesity	1.39e-05	0.000207	CcSEcCtD
Escitalopram—Vertigo—Bupropion—obesity	1.38e-05	0.000206	CcSEcCtD
Escitalopram—Syncope—Bupropion—obesity	1.38e-05	0.000206	CcSEcCtD
Escitalopram—Pancreatitis—Topiramate—obesity	1.38e-05	0.000205	CcSEcCtD
Escitalopram—Leukopenia—Bupropion—obesity	1.38e-05	0.000205	CcSEcCtD
Escitalopram—Anorexia—Sibutramine—obesity	1.37e-05	0.000205	CcSEcCtD
Escitalopram—Angina pectoris—Topiramate—obesity	1.37e-05	0.000204	CcSEcCtD
Escitalopram—Sweating increased—Topiramate—obesity	1.37e-05	0.000204	CcSEcCtD
Escitalopram—Palpitations—Bupropion—obesity	1.36e-05	0.000203	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Orlistat—obesity	1.36e-05	0.000202	CcSEcCtD
Escitalopram—Bronchitis—Topiramate—obesity	1.35e-05	0.000202	CcSEcCtD
Escitalopram—Loss of consciousness—Bupropion—obesity	1.35e-05	0.000201	CcSEcCtD
Escitalopram—Abdominal discomfort—Topiramate—obesity	1.35e-05	0.000201	CcSEcCtD
Escitalopram—Insomnia—Orlistat—obesity	1.35e-05	0.000201	CcSEcCtD
Escitalopram—Hypotension—Sibutramine—obesity	1.35e-05	0.0002	CcSEcCtD
Escitalopram—Cough—Bupropion—obesity	1.34e-05	0.0002	CcSEcCtD
Escitalopram—Paraesthesia—Orlistat—obesity	1.34e-05	0.000199	CcSEcCtD
Escitalopram—Pancytopenia—Topiramate—obesity	1.34e-05	0.000199	CcSEcCtD
Escitalopram—Convulsion—Bupropion—obesity	1.33e-05	0.000199	CcSEcCtD
Escitalopram—Hypertension—Bupropion—obesity	1.33e-05	0.000198	CcSEcCtD
Escitalopram—Dysuria—Topiramate—obesity	1.32e-05	0.000196	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Sibutramine—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Dyspepsia—Orlistat—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Myalgia—Bupropion—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Chest pain—Bupropion—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Arthralgia—Bupropion—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Topiramate—obesity	1.31e-05	0.000195	CcSEcCtD
Escitalopram—Anxiety—Bupropion—obesity	1.31e-05	0.000194	CcSEcCtD
Escitalopram—Insomnia—Sibutramine—obesity	1.3e-05	0.000194	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	1.3e-05	0.000194	CcSEcCtD
Escitalopram—Pollakiuria—Topiramate—obesity	1.3e-05	0.000194	CcSEcCtD
Escitalopram—Erectile dysfunction—Topiramate—obesity	1.3e-05	0.000193	CcSEcCtD
Escitalopram—Discomfort—Bupropion—obesity	1.3e-05	0.000193	CcSEcCtD
Escitalopram—Decreased appetite—Orlistat—obesity	1.3e-05	0.000193	CcSEcCtD
Escitalopram—Paraesthesia—Sibutramine—obesity	1.3e-05	0.000193	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Orlistat—obesity	1.29e-05	0.000191	CcSEcCtD
Escitalopram—Dyspnoea—Sibutramine—obesity	1.29e-05	0.000191	CcSEcCtD
Escitalopram—Photosensitivity reaction—Topiramate—obesity	1.29e-05	0.000191	CcSEcCtD
Escitalopram—Fatigue—Orlistat—obesity	1.28e-05	0.000191	CcSEcCtD
Escitalopram—Dry mouth—Bupropion—obesity	1.28e-05	0.000191	CcSEcCtD
Escitalopram—Somnolence—Sibutramine—obesity	1.28e-05	0.000191	CcSEcCtD
Escitalopram—Weight increased—Topiramate—obesity	1.28e-05	0.000191	CcSEcCtD
Escitalopram—Weight decreased—Topiramate—obesity	1.27e-05	0.00019	CcSEcCtD
Escitalopram—Pain—Orlistat—obesity	1.27e-05	0.00019	CcSEcCtD
Escitalopram—Hyperglycaemia—Topiramate—obesity	1.27e-05	0.000189	CcSEcCtD
Escitalopram—Dyspepsia—Sibutramine—obesity	1.27e-05	0.000189	CcSEcCtD
Escitalopram—Confusional state—Bupropion—obesity	1.27e-05	0.000189	CcSEcCtD
Escitalopram—Pneumonia—Topiramate—obesity	1.26e-05	0.000188	CcSEcCtD
Escitalopram—Oedema—Bupropion—obesity	1.26e-05	0.000187	CcSEcCtD
Escitalopram—Anaphylactic shock—Bupropion—obesity	1.26e-05	0.000187	CcSEcCtD
Escitalopram—Infestation NOS—Topiramate—obesity	1.26e-05	0.000187	CcSEcCtD
Escitalopram—Infestation—Topiramate—obesity	1.26e-05	0.000187	CcSEcCtD
Escitalopram—Decreased appetite—Sibutramine—obesity	1.25e-05	0.000187	CcSEcCtD
Escitalopram—Depression—Topiramate—obesity	1.25e-05	0.000186	CcSEcCtD
Escitalopram—Infection—Bupropion—obesity	1.25e-05	0.000186	CcSEcCtD
Escitalopram—Stevens-Johnson syndrome—Topiramate—obesity	1.25e-05	0.000185	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Sibutramine—obesity	1.25e-05	0.000185	CcSEcCtD
Escitalopram—Shock—Bupropion—obesity	1.24e-05	0.000184	CcSEcCtD
Escitalopram—Constipation—Sibutramine—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Pain—Sibutramine—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Nervous system disorder—Bupropion—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Neuropathy peripheral—Topiramate—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Thrombocytopenia—Bupropion—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Feeling abnormal—Orlistat—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Tachycardia—Bupropion—obesity	1.23e-05	0.000183	CcSEcCtD
Escitalopram—Stomatitis—Topiramate—obesity	1.22e-05	0.000182	CcSEcCtD
Escitalopram—Skin disorder—Bupropion—obesity	1.22e-05	0.000182	CcSEcCtD
Escitalopram—Urinary tract infection—Topiramate—obesity	1.22e-05	0.000182	CcSEcCtD
Escitalopram—Conjunctivitis—Topiramate—obesity	1.22e-05	0.000182	CcSEcCtD
Escitalopram—Gastrointestinal pain—Orlistat—obesity	1.22e-05	0.000181	CcSEcCtD
Escitalopram—Hyperhidrosis—Bupropion—obesity	1.22e-05	0.000181	CcSEcCtD
Escitalopram—Anorexia—Bupropion—obesity	1.2e-05	0.000178	CcSEcCtD
Escitalopram—Haematuria—Topiramate—obesity	1.2e-05	0.000178	CcSEcCtD
Escitalopram—Feeling abnormal—Sibutramine—obesity	1.19e-05	0.000177	CcSEcCtD
Escitalopram—Epistaxis—Topiramate—obesity	1.18e-05	0.000176	CcSEcCtD
Escitalopram—Urticaria—Orlistat—obesity	1.18e-05	0.000176	CcSEcCtD
Escitalopram—Gastrointestinal pain—Sibutramine—obesity	1.18e-05	0.000175	CcSEcCtD
Escitalopram—Sinusitis—Topiramate—obesity	1.18e-05	0.000175	CcSEcCtD
Escitalopram—Abdominal pain—Orlistat—obesity	1.18e-05	0.000175	CcSEcCtD
Escitalopram—Body temperature increased—Orlistat—obesity	1.18e-05	0.000175	CcSEcCtD
Escitalopram—Hypotension—Bupropion—obesity	1.17e-05	0.000175	CcSEcCtD
Escitalopram—Agranulocytosis—Topiramate—obesity	1.17e-05	0.000174	CcSEcCtD
Escitalopram—Bradycardia—Topiramate—obesity	1.15e-05	0.000171	CcSEcCtD
Escitalopram—Urticaria—Sibutramine—obesity	1.15e-05	0.00017	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Bupropion—obesity	1.15e-05	0.00017	CcSEcCtD
Escitalopram—Abdominal pain—Sibutramine—obesity	1.14e-05	0.00017	CcSEcCtD
Escitalopram—Body temperature increased—Sibutramine—obesity	1.14e-05	0.00017	CcSEcCtD
Escitalopram—Insomnia—Bupropion—obesity	1.14e-05	0.000169	CcSEcCtD
Escitalopram—Haemoglobin—Topiramate—obesity	1.13e-05	0.000169	CcSEcCtD
Escitalopram—Rhinitis—Topiramate—obesity	1.13e-05	0.000168	CcSEcCtD
Escitalopram—Paraesthesia—Bupropion—obesity	1.13e-05	0.000168	CcSEcCtD
Escitalopram—Haemorrhage—Topiramate—obesity	1.13e-05	0.000168	CcSEcCtD
Escitalopram—Hepatitis—Topiramate—obesity	1.13e-05	0.000168	CcSEcCtD
Escitalopram—Hallucination—Topiramate—obesity	1.12e-05	0.000167	CcSEcCtD
Escitalopram—Hypoaesthesia—Topiramate—obesity	1.12e-05	0.000167	CcSEcCtD
Escitalopram—Dyspnoea—Bupropion—obesity	1.12e-05	0.000167	CcSEcCtD
Escitalopram—Pharyngitis—Topiramate—obesity	1.12e-05	0.000166	CcSEcCtD
Escitalopram—Somnolence—Bupropion—obesity	1.12e-05	0.000166	CcSEcCtD
Escitalopram—Urinary tract disorder—Topiramate—obesity	1.11e-05	0.000166	CcSEcCtD
Escitalopram—Oedema peripheral—Topiramate—obesity	1.11e-05	0.000165	CcSEcCtD
Escitalopram—Connective tissue disorder—Topiramate—obesity	1.11e-05	0.000165	CcSEcCtD
Escitalopram—Dyspepsia—Bupropion—obesity	1.11e-05	0.000165	CcSEcCtD
Escitalopram—Urethral disorder—Topiramate—obesity	1.11e-05	0.000164	CcSEcCtD
Escitalopram—Hypersensitivity—Orlistat—obesity	1.1e-05	0.000163	CcSEcCtD
Escitalopram—Decreased appetite—Bupropion—obesity	1.09e-05	0.000163	CcSEcCtD
Escitalopram—Visual impairment—Topiramate—obesity	1.09e-05	0.000162	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Bupropion—obesity	1.09e-05	0.000161	CcSEcCtD
Escitalopram—Fatigue—Bupropion—obesity	1.08e-05	0.000161	CcSEcCtD
Escitalopram—Pain—Bupropion—obesity	1.08e-05	0.00016	CcSEcCtD
Escitalopram—Constipation—Bupropion—obesity	1.08e-05	0.00016	CcSEcCtD
Escitalopram—Asthenia—Orlistat—obesity	1.07e-05	0.000159	CcSEcCtD
Escitalopram—Erythema multiforme—Topiramate—obesity	1.07e-05	0.000159	CcSEcCtD
Escitalopram—Hypersensitivity—Sibutramine—obesity	1.06e-05	0.000158	CcSEcCtD
Escitalopram—Pruritus—Orlistat—obesity	1.05e-05	0.000157	CcSEcCtD
Escitalopram—Eye disorder—Topiramate—obesity	1.05e-05	0.000157	CcSEcCtD
Escitalopram—Tinnitus—Topiramate—obesity	1.05e-05	0.000156	CcSEcCtD
Escitalopram—Flushing—Topiramate—obesity	1.05e-05	0.000156	CcSEcCtD
Escitalopram—Cardiac disorder—Topiramate—obesity	1.05e-05	0.000156	CcSEcCtD
Escitalopram—Feeling abnormal—Bupropion—obesity	1.04e-05	0.000154	CcSEcCtD
Escitalopram—Asthenia—Sibutramine—obesity	1.03e-05	0.000154	CcSEcCtD
Escitalopram—Gastrointestinal pain—Bupropion—obesity	1.03e-05	0.000153	CcSEcCtD
Escitalopram—Angiopathy—Topiramate—obesity	1.02e-05	0.000152	CcSEcCtD
Escitalopram—Pruritus—Sibutramine—obesity	1.02e-05	0.000152	CcSEcCtD
Escitalopram—Diarrhoea—Orlistat—obesity	1.02e-05	0.000152	CcSEcCtD
Escitalopram—Immune system disorder—Topiramate—obesity	1.02e-05	0.000152	CcSEcCtD
Escitalopram—Mediastinal disorder—Topiramate—obesity	1.02e-05	0.000151	CcSEcCtD
Escitalopram—Chills—Topiramate—obesity	1.01e-05	0.000151	CcSEcCtD
Escitalopram—Urticaria—Bupropion—obesity	9.99e-06	0.000149	CcSEcCtD
Escitalopram—Alopecia—Topiramate—obesity	9.96e-06	0.000148	CcSEcCtD
Escitalopram—Abdominal pain—Bupropion—obesity	9.94e-06	0.000148	CcSEcCtD
Escitalopram—Body temperature increased—Bupropion—obesity	9.94e-06	0.000148	CcSEcCtD
Escitalopram—Mental disorder—Topiramate—obesity	9.88e-06	0.000147	CcSEcCtD
Escitalopram—Diarrhoea—Sibutramine—obesity	9.87e-06	0.000147	CcSEcCtD
Escitalopram—Dizziness—Orlistat—obesity	9.86e-06	0.000147	CcSEcCtD
Escitalopram—Malnutrition—Topiramate—obesity	9.82e-06	0.000146	CcSEcCtD
Escitalopram—Erythema—Topiramate—obesity	9.82e-06	0.000146	CcSEcCtD
Escitalopram—Flatulence—Topiramate—obesity	9.67e-06	0.000144	CcSEcCtD
Escitalopram—Tension—Topiramate—obesity	9.63e-06	0.000143	CcSEcCtD
Escitalopram—Dysgeusia—Topiramate—obesity	9.61e-06	0.000143	CcSEcCtD
Escitalopram—Dizziness—Sibutramine—obesity	9.54e-06	0.000142	CcSEcCtD
Escitalopram—Nervousness—Topiramate—obesity	9.53e-06	0.000142	CcSEcCtD
Escitalopram—Back pain—Topiramate—obesity	9.49e-06	0.000141	CcSEcCtD
Escitalopram—Vomiting—Orlistat—obesity	9.48e-06	0.000141	CcSEcCtD
Escitalopram—Muscle spasms—Topiramate—obesity	9.44e-06	0.00014	CcSEcCtD
Escitalopram—Rash—Orlistat—obesity	9.4e-06	0.00014	CcSEcCtD
Escitalopram—Dermatitis—Orlistat—obesity	9.39e-06	0.00014	CcSEcCtD
Escitalopram—Headache—Orlistat—obesity	9.34e-06	0.000139	CcSEcCtD
Escitalopram—Hypersensitivity—Bupropion—obesity	9.26e-06	0.000138	CcSEcCtD
Escitalopram—Vision blurred—Topiramate—obesity	9.25e-06	0.000138	CcSEcCtD
Escitalopram—Tremor—Topiramate—obesity	9.2e-06	0.000137	CcSEcCtD
Escitalopram—Vomiting—Sibutramine—obesity	9.17e-06	0.000136	CcSEcCtD
Escitalopram—Ill-defined disorder—Topiramate—obesity	9.11e-06	0.000135	CcSEcCtD
Escitalopram—Rash—Sibutramine—obesity	9.09e-06	0.000135	CcSEcCtD
Escitalopram—Dermatitis—Sibutramine—obesity	9.09e-06	0.000135	CcSEcCtD
Escitalopram—Anaemia—Topiramate—obesity	9.07e-06	0.000135	CcSEcCtD
Escitalopram—Headache—Sibutramine—obesity	9.04e-06	0.000134	CcSEcCtD
Escitalopram—Asthenia—Bupropion—obesity	9.02e-06	0.000134	CcSEcCtD
Escitalopram—Agitation—Topiramate—obesity	9.02e-06	0.000134	CcSEcCtD
Escitalopram—Pruritus—Bupropion—obesity	8.9e-06	0.000132	CcSEcCtD
Escitalopram—Nausea—Orlistat—obesity	8.85e-06	0.000132	CcSEcCtD
Escitalopram—Malaise—Topiramate—obesity	8.85e-06	0.000132	CcSEcCtD
Escitalopram—Vertigo—Topiramate—obesity	8.82e-06	0.000131	CcSEcCtD
Escitalopram—Syncope—Topiramate—obesity	8.8e-06	0.000131	CcSEcCtD
Escitalopram—Leukopenia—Topiramate—obesity	8.79e-06	0.000131	CcSEcCtD
Escitalopram—Palpitations—Topiramate—obesity	8.67e-06	0.000129	CcSEcCtD
Escitalopram—Loss of consciousness—Topiramate—obesity	8.63e-06	0.000128	CcSEcCtD
Escitalopram—Diarrhoea—Bupropion—obesity	8.6e-06	0.000128	CcSEcCtD
Escitalopram—Nausea—Sibutramine—obesity	8.57e-06	0.000127	CcSEcCtD
Escitalopram—Cough—Topiramate—obesity	8.57e-06	0.000127	CcSEcCtD
Escitalopram—Convulsion—Topiramate—obesity	8.5e-06	0.000127	CcSEcCtD
Escitalopram—Hypertension—Topiramate—obesity	8.47e-06	0.000126	CcSEcCtD
Escitalopram—Myalgia—Topiramate—obesity	8.36e-06	0.000124	CcSEcCtD
Escitalopram—Arthralgia—Topiramate—obesity	8.36e-06	0.000124	CcSEcCtD
Escitalopram—Chest pain—Topiramate—obesity	8.36e-06	0.000124	CcSEcCtD
Escitalopram—Anxiety—Topiramate—obesity	8.33e-06	0.000124	CcSEcCtD
Escitalopram—Dizziness—Bupropion—obesity	8.31e-06	0.000124	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	8.3e-06	0.000123	CcSEcCtD
Escitalopram—Discomfort—Topiramate—obesity	8.26e-06	0.000123	CcSEcCtD
Escitalopram—Dry mouth—Topiramate—obesity	8.17e-06	0.000122	CcSEcCtD
Escitalopram—Confusional state—Topiramate—obesity	8.08e-06	0.00012	CcSEcCtD
Escitalopram—Oedema—Topiramate—obesity	8.01e-06	0.000119	CcSEcCtD
Escitalopram—Vomiting—Bupropion—obesity	7.99e-06	0.000119	CcSEcCtD
Escitalopram—Infection—Topiramate—obesity	7.96e-06	0.000118	CcSEcCtD
Escitalopram—Rash—Bupropion—obesity	7.93e-06	0.000118	CcSEcCtD
Escitalopram—Dermatitis—Bupropion—obesity	7.92e-06	0.000118	CcSEcCtD
Escitalopram—Shock—Topiramate—obesity	7.88e-06	0.000117	CcSEcCtD
Escitalopram—Headache—Bupropion—obesity	7.88e-06	0.000117	CcSEcCtD
Escitalopram—Nervous system disorder—Topiramate—obesity	7.86e-06	0.000117	CcSEcCtD
Escitalopram—Thrombocytopenia—Topiramate—obesity	7.84e-06	0.000117	CcSEcCtD
Escitalopram—Tachycardia—Topiramate—obesity	7.82e-06	0.000116	CcSEcCtD
Escitalopram—Skin disorder—Topiramate—obesity	7.78e-06	0.000116	CcSEcCtD
Escitalopram—Hyperhidrosis—Topiramate—obesity	7.74e-06	0.000115	CcSEcCtD
Escitalopram—Anorexia—Topiramate—obesity	7.64e-06	0.000114	CcSEcCtD
Escitalopram—Hypotension—Topiramate—obesity	7.49e-06	0.000111	CcSEcCtD
Escitalopram—Nausea—Bupropion—obesity	7.47e-06	0.000111	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Topiramate—obesity	7.3e-06	0.000109	CcSEcCtD
Escitalopram—Insomnia—Topiramate—obesity	7.25e-06	0.000108	CcSEcCtD
Escitalopram—Paraesthesia—Topiramate—obesity	7.19e-06	0.000107	CcSEcCtD
Escitalopram—Dyspnoea—Topiramate—obesity	7.14e-06	0.000106	CcSEcCtD
Escitalopram—Somnolence—Topiramate—obesity	7.12e-06	0.000106	CcSEcCtD
Escitalopram—Dyspepsia—Topiramate—obesity	7.05e-06	0.000105	CcSEcCtD
Escitalopram—Decreased appetite—Topiramate—obesity	6.96e-06	0.000104	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Topiramate—obesity	6.92e-06	0.000103	CcSEcCtD
Escitalopram—Fatigue—Topiramate—obesity	6.91e-06	0.000103	CcSEcCtD
Escitalopram—Pain—Topiramate—obesity	6.85e-06	0.000102	CcSEcCtD
Escitalopram—Constipation—Topiramate—obesity	6.85e-06	0.000102	CcSEcCtD
Escitalopram—Feeling abnormal—Topiramate—obesity	6.6e-06	9.82e-05	CcSEcCtD
Escitalopram—Gastrointestinal pain—Topiramate—obesity	6.55e-06	9.74e-05	CcSEcCtD
Escitalopram—Urticaria—Topiramate—obesity	6.36e-06	9.47e-05	CcSEcCtD
Escitalopram—Abdominal pain—Topiramate—obesity	6.33e-06	9.42e-05	CcSEcCtD
Escitalopram—Body temperature increased—Topiramate—obesity	6.33e-06	9.42e-05	CcSEcCtD
Escitalopram—Hypersensitivity—Topiramate—obesity	5.9e-06	8.78e-05	CcSEcCtD
Escitalopram—Asthenia—Topiramate—obesity	5.75e-06	8.55e-05	CcSEcCtD
Escitalopram—Pruritus—Topiramate—obesity	5.67e-06	8.43e-05	CcSEcCtD
Escitalopram—Diarrhoea—Topiramate—obesity	5.48e-06	8.15e-05	CcSEcCtD
Escitalopram—Dizziness—Topiramate—obesity	5.3e-06	7.88e-05	CcSEcCtD
Escitalopram—Vomiting—Topiramate—obesity	5.09e-06	7.58e-05	CcSEcCtD
Escitalopram—Rash—Topiramate—obesity	5.05e-06	7.51e-05	CcSEcCtD
Escitalopram—Dermatitis—Topiramate—obesity	5.05e-06	7.51e-05	CcSEcCtD
Escitalopram—Headache—Topiramate—obesity	5.02e-06	7.47e-05	CcSEcCtD
Escitalopram—Nausea—Topiramate—obesity	4.76e-06	7.08e-05	CcSEcCtD
Escitalopram—HRH1—Signaling Pathways—AGT—obesity	1.02e-06	3.61e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GLP1R—obesity	1.02e-06	3.6e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SULT2A1—obesity	1.02e-06	3.6e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS2—obesity	1.02e-06	3.6e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—obesity	1.02e-06	3.59e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—STK11—obesity	1.02e-06	3.59e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP19A1—obesity	1.02e-06	3.59e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARGC1A—obesity	1.01e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GNB3—obesity	1.01e-06	3.58e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—obesity	1.01e-06	3.56e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS2—obesity	1.01e-06	3.54e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DPYD—obesity	1e-06	3.54e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—obesity	1e-06	3.54e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—obesity	1e-06	3.53e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—obesity	1e-06	3.53e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—obesity	9.99e-07	3.52e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—obesity	9.99e-07	3.52e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—obesity	9.94e-07	3.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CAV1—obesity	9.93e-07	3.5e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—obesity	9.91e-07	3.49e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CAV1—obesity	9.9e-07	3.49e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—obesity	9.88e-07	3.48e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GNAS—obesity	9.88e-07	3.48e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—obesity	9.88e-07	3.48e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—obesity	9.84e-07	3.47e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—obesity	9.84e-07	3.47e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CAV1—obesity	9.75e-07	3.43e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—obesity	9.72e-07	3.43e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—obesity	9.72e-07	3.43e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOB—obesity	9.68e-07	3.41e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PRKAR2B—obesity	9.67e-07	3.41e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DCN—obesity	9.6e-07	3.38e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ESR1—obesity	9.57e-07	3.37e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—obesity	9.56e-07	3.37e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT2—obesity	9.55e-07	3.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ESR1—obesity	9.54e-07	3.36e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—COMT—obesity	9.47e-07	3.34e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—F2—obesity	9.45e-07	3.33e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCB—obesity	9.45e-07	3.33e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—F2—obesity	9.42e-07	3.32e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCB—obesity	9.42e-07	3.32e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ESR1—obesity	9.39e-07	3.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CPT1A—obesity	9.34e-07	3.29e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—BAD—obesity	9.34e-07	3.29e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARGC1A—obesity	9.33e-07	3.29e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GNB3—obesity	9.33e-07	3.29e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—BAD—obesity	9.31e-07	3.28e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—obesity	9.29e-07	3.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCB—obesity	9.28e-07	3.27e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—F2—obesity	9.28e-07	3.27e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—obesity	9.24e-07	3.26e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CD—obesity	9.18e-07	3.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—BAD—obesity	9.17e-07	3.23e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NAMPT—obesity	9.16e-07	3.23e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—obesity	9.1e-07	3.21e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCK—obesity	9.1e-07	3.21e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PIK3CA—obesity	9.09e-07	3.2e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GNAS—obesity	9.09e-07	3.2e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—obesity	9.08e-07	3.2e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOC3—obesity	9.05e-07	3.19e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CG—obesity	9.05e-07	3.19e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CG—obesity	9.02e-07	3.18e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GPX1—obesity	9.01e-07	3.18e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS1—obesity	8.94e-07	3.15e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS1—obesity	8.91e-07	3.14e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOB—obesity	8.9e-07	3.14e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CG—obesity	8.88e-07	3.13e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TYK2—obesity	8.83e-07	3.11e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CETP—obesity	8.78e-07	3.1e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD36—obesity	8.78e-07	3.09e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS1—obesity	8.78e-07	3.09e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RHOA—obesity	8.76e-07	3.09e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SDC1—obesity	8.68e-07	3.06e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3R1—obesity	8.67e-07	3.05e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—obesity	8.67e-07	3.05e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—obesity	8.61e-07	3.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—obesity	8.58e-07	3.02e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—obesity	8.56e-07	3.02e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKR1C3—obesity	8.54e-07	3.01e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—obesity	8.54e-07	3.01e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—obesity	8.5e-07	2.99e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—obesity	8.45e-07	2.98e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—obesity	8.43e-07	2.97e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SCARB1—obesity	8.41e-07	2.96e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—obesity	8.4e-07	2.96e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—obesity	8.4e-07	2.96e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—obesity	8.32e-07	2.93e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GPX1—obesity	8.29e-07	2.92e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—obesity	8.28e-07	2.92e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT2—obesity	8.28e-07	2.92e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—obesity	8.27e-07	2.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—obesity	8.26e-07	2.91e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PIK3CA—obesity	8.26e-07	2.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT2—obesity	8.25e-07	2.91e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF1—obesity	8.17e-07	2.88e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—obesity	8.16e-07	2.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—obesity	8.13e-07	2.86e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT2—obesity	8.12e-07	2.86e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD36—obesity	8.07e-07	2.85e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MTOR—obesity	8e-07	2.82e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CB—obesity	8e-07	2.82e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CD—obesity	7.95e-07	2.8e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT2—obesity	7.94e-07	2.8e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CD—obesity	7.93e-07	2.79e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—obesity	7.9e-07	2.79e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CA—obesity	7.88e-07	2.78e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—obesity	7.87e-07	2.77e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CA—obesity	7.85e-07	2.77e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—obesity	7.84e-07	2.76e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CD—obesity	7.8e-07	2.75e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FASN—obesity	7.77e-07	2.74e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—obesity	7.74e-07	2.73e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—BCHE—obesity	7.74e-07	2.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	7.73e-07	2.72e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—obesity	7.72e-07	2.72e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAV1—obesity	7.67e-07	2.7e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—obesity	7.66e-07	2.7e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TYK2—obesity	7.65e-07	2.7e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—obesity	7.65e-07	2.7e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TYK2—obesity	7.63e-07	2.69e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RHOA—obesity	7.59e-07	2.67e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RHOA—obesity	7.56e-07	2.67e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—obesity	7.51e-07	2.65e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3R1—obesity	7.51e-07	2.65e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TYK2—obesity	7.51e-07	2.65e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—obesity	7.51e-07	2.64e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3R1—obesity	7.49e-07	2.64e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—obesity	7.49e-07	2.64e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2E1—obesity	7.47e-07	2.63e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RHOA—obesity	7.45e-07	2.62e-05	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—obesity	7.43e-07	2.62e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NQO1—obesity	7.38e-07	2.6e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—obesity	7.37e-07	2.6e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3R1—obesity	7.37e-07	2.6e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.33e-07	2.58e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—obesity	7.31e-07	2.58e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—obesity	7.27e-07	2.56e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CA—obesity	7.15e-07	2.52e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CA—obesity	7.13e-07	2.51e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—obesity	7.12e-07	2.51e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCG—obesity	7.08e-07	2.49e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A4—obesity	7.08e-07	2.49e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAV1—obesity	7.06e-07	2.49e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—obesity	7.04e-07	2.48e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CA—obesity	7.02e-07	2.47e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CG—obesity	6.99e-07	2.46e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYCS—obesity	6.99e-07	2.46e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—obesity	6.95e-07	2.45e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MTOR—obesity	6.93e-07	2.44e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CB—obesity	6.93e-07	2.44e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CB—obesity	6.91e-07	2.44e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MTOR—obesity	6.91e-07	2.44e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—obesity	6.86e-07	2.42e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT1—obesity	6.86e-07	2.42e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CB—obesity	6.8e-07	2.4e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MTOR—obesity	6.8e-07	2.4e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK8—obesity	6.76e-07	2.38e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NCOA1—obesity	6.75e-07	2.38e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—obesity	6.75e-07	2.38e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—obesity	6.74e-07	2.38e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP19A1—obesity	6.66e-07	2.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—STK11—obesity	6.66e-07	2.35e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—obesity	6.65e-07	2.34e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—obesity	6.62e-07	2.33e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—obesity	6.44e-07	2.27e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CG—obesity	6.43e-07	2.27e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—obesity	6.41e-07	2.26e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—obesity	6.33e-07	2.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—obesity	6.31e-07	2.23e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—obesity	6.31e-07	2.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—obesity	6.22e-07	2.19e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—obesity	6.2e-07	2.19e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—COMT—obesity	6.19e-07	2.18e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—obesity	6.18e-07	2.18e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CD—obesity	6.14e-07	2.17e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—obesity	6.12e-07	2.16e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARGC1A—obesity	6.1e-07	2.15e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GNB3—obesity	6.1e-07	2.15e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—obesity	6.08e-07	2.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—obesity	6.07e-07	2.14e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—obesity	6.07e-07	2.14e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—obesity	6.03e-07	2.12e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—obesity	6.01e-07	2.12e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GNAS—obesity	5.94e-07	2.09e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—obesity	5.91e-07	2.08e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK8—obesity	5.86e-07	2.07e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—obesity	5.84e-07	2.06e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK8—obesity	5.84e-07	2.06e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—obesity	5.83e-07	2.05e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOB—obesity	5.82e-07	2.05e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3R1—obesity	5.8e-07	2.04e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—obesity	5.8e-07	2.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK8—obesity	5.75e-07	2.03e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—obesity	5.75e-07	2.02e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—obesity	5.73e-07	2.02e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—obesity	5.73e-07	2.02e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CD—obesity	5.65e-07	1.99e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—obesity	5.58e-07	1.97e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—obesity	5.56e-07	1.96e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GPX1—obesity	5.42e-07	1.91e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—obesity	5.36e-07	1.89e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CB—obesity	5.36e-07	1.89e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—obesity	5.34e-07	1.88e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—obesity	5.34e-07	1.88e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3R1—obesity	5.34e-07	1.88e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—obesity	5.31e-07	1.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD36—obesity	5.28e-07	1.86e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—obesity	5.26e-07	1.85e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—obesity	5e-07	1.76e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—obesity	4.98e-07	1.75e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—obesity	4.97e-07	1.75e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—obesity	4.96e-07	1.75e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—obesity	4.95e-07	1.74e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CB—obesity	4.93e-07	1.74e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—obesity	4.91e-07	1.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—obesity	4.88e-07	1.72e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—obesity	4.88e-07	1.72e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CA—obesity	4.88e-07	1.72e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—obesity	4.87e-07	1.72e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—obesity	4.75e-07	1.67e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—obesity	4.66e-07	1.64e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAV1—obesity	4.61e-07	1.63e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—obesity	4.6e-07	1.62e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—obesity	4.32e-07	1.52e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CA—obesity	4.23e-07	1.49e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CA—obesity	4.21e-07	1.48e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CG—obesity	4.2e-07	1.48e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CA—obesity	4.15e-07	1.46e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—obesity	4.06e-07	1.43e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—obesity	4e-07	1.41e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—obesity	3.98e-07	1.4e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—obesity	3.98e-07	1.4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—obesity	3.74e-07	1.32e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—obesity	3.73e-07	1.31e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CD—obesity	3.69e-07	1.3e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—obesity	3.67e-07	1.29e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—obesity	3.65e-07	1.29e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—obesity	3.49e-07	1.23e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3R1—obesity	3.49e-07	1.23e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—obesity	3.45e-07	1.22e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—obesity	3.44e-07	1.21e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—obesity	3.39e-07	1.19e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CA—obesity	3.26e-07	1.15e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CB—obesity	3.22e-07	1.13e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—obesity	3.19e-07	1.12e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CA—obesity	3e-07	1.06e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—obesity	2.67e-07	9.4e-06	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—obesity	2.45e-07	8.64e-06	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CA—obesity	1.96e-07	6.92e-06	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—obesity	1.6e-07	5.65e-06	CbGpPWpGaD
